Report Detail
Global Irritable Bowel Syndrome (IBS) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM2974949 |
- 18 February, 2019 |
- Global |
- 115 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Scope of the Report:
Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.
The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.
The worldwide market for Irritable Bowel Syndrome (IBS) is expected to grow at a CAGR of roughly 16.3% over the next five years, will reach 6530 million US$ in 2024, from 2640 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Irritable Bowel Syndrome (IBS) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Allergan
Valeant Pharmaceuticals
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
IBS-D Drug
IBS-C Drug
Other
Market Segment by Applications, can be divided into
Women
Men
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Irritable Bowel Syndrome (IBS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Irritable Bowel Syndrome (IBS), with price, sales, revenue and global market share of Irritable Bowel Syndrome (IBS) in 2017 and 2018.
Chapter 3, the Irritable Bowel Syndrome (IBS) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Irritable Bowel Syndrome (IBS) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Irritable Bowel Syndrome (IBS) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Irritable Bowel Syndrome (IBS) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Irritable Bowel Syndrome (IBS) Introduction
- 1.2 Market Analysis by Type
- 1.2.1 IBS-D Drug
- 1.2.2 IBS-C Drug
- 1.2.3 Other
- 1.3 Market Analysis by Applications
- 1.3.1 Women
- 1.3.2 Men
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Allergan
- 2.1.1 Business Overview
- 2.1.2 Irritable Bowel Syndrome (IBS) Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Valeant Pharmaceuticals
- 2.2.1 Business Overview
- 2.2.2 Irritable Bowel Syndrome (IBS) Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Takeda
- 2.3.1 Business Overview
- 2.3.2 Irritable Bowel Syndrome (IBS) Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Sucampo Pharmaceuticals
- 2.4.1 Business Overview
- 2.4.2 Irritable Bowel Syndrome (IBS) Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 McNeil Consumer Healthcare
- 2.5.1 Business Overview
- 2.5.2 Irritable Bowel Syndrome (IBS) Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Sebela Pharmaceuticals
- 2.6.1 Business Overview
- 2.6.2 Irritable Bowel Syndrome (IBS) Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.7 Astellas Pharmaceuticals
- 2.7.1 Business Overview
- 2.7.2 Irritable Bowel Syndrome (IBS) Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.8 IM HealthScience
- 2.8.1 Business Overview
- 2.8.2 Irritable Bowel Syndrome (IBS) Type and Applications
- 2.8.2.1 Product A
- 2.8.2.2 Product B
- 2.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Irritable Bowel Syndrome (IBS) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Irritable Bowel Syndrome (IBS) Manufacturer Market Share in 2018
- 3.3.2 Top 6 Irritable Bowel Syndrome (IBS) Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Irritable Bowel Syndrome (IBS) Market Analysis by Regions
- 4.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Regions
- 4.1.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 4.3 Europe Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 4.5 South America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
5 North America Irritable Bowel Syndrome (IBS) by Country
- 5.1 North America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country
- 5.1.1 North America Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)
- 5.2 United States Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 5.3 Canada Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 5.4 Mexico Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
6 Europe Irritable Bowel Syndrome (IBS) by Country
- 6.1 Europe Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country
- 6.1.1 Europe Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 6.3 UK Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 6.4 France Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 6.5 Russia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 6.6 Italy Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
7 Asia-Pacific Irritable Bowel Syndrome (IBS) by Country
- 7.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)
- 7.2 China Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 7.3 Japan Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 7.4 Korea Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 7.5 India Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
8 South America Irritable Bowel Syndrome (IBS) by Country
- 8.1 South America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country
- 8.1.1 South America Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 8.3 Argentina Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 8.4 Colombia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
9 Middle East and Africa Irritable Bowel Syndrome (IBS) by Countries
- 9.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 9.3 Turkey Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 9.4 Egypt Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
- 9.6 South Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2014-2019)
10 Global Irritable Bowel Syndrome (IBS) Market Segment by Type
- 10.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2014-2019)
- 10.2 IBS-D Drug Sales Growth and Price
- 10.2.1 Global IBS-D Drug Sales Growth (2014-2019)
- 10.2.2 Global IBS-D Drug Price (2014-2019)
- 10.3 IBS-C Drug Sales Growth and Price
- 10.3.1 Global IBS-C Drug Sales Growth (2014-2019)
- 10.3.2 Global IBS-C Drug Price (2014-2019)
- 10.4 Other Sales Growth and Price
- 10.4.1 Global Other Sales Growth (2014-2019)
- 10.4.2 Global Other Price (2014-2019)
11 Global Irritable Bowel Syndrome (IBS) Market Segment by Application
- 11.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2014-2019)
- 11.2 Women Sales Growth (2014-2019)
- 11.3 Men Sales Growth (2014-2019)
12 Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
- 12.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Irritable Bowel Syndrome (IBS) Market Forecast by Regions (2019-2024)
- 12.2.1 North America Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
- 12.2.2 Europe Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
- 12.2.4 South America Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Forecast (2019-2024)
- 12.3 Irritable Bowel Syndrome (IBS) Market Forecast by Type (2019-2024)
- 12.3.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2019-2024)
- 12.3.2 Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2019-2024)
- 12.4 Irritable Bowel Syndrome (IBS) Market Forecast by Application (2019-2024)
- 12.4.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2019-2024)
- 12.4.2 Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Irritable Bowel Syndrome (IBS) . Industry analysis & Market Report on Irritable Bowel Syndrome (IBS) is a syndicated market report, published as Global Irritable Bowel Syndrome (IBS) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Irritable Bowel Syndrome (IBS) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
